Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 4:16 pm Sale | 13G | TRICIDA INC TCDAQ | Point72 Asset Management L.P. | 167,509 0.300% | -3,117,394 (-94.90%) | View |
| 2023-02-14 12:19 pm Sale | 13G | TRICIDA INC TCDAQ | Frazier Life Sciences Public Fund L.P. | 1,500,000 2.500% | -2,082,093 (-58.13%) | View |
| 2023-02-14 08:58 am Sale | 13G | TRICIDA INC TCDAQ | Deep Track Capital LP | 4,666,666 7.440% | -1,191,163 (-20.33%) | View |
| 2023-02-14 08:14 am Sale | 13G | TRICIDA INC TCDAQ | CITADEL ADVISORS LLC | 541,341 0.900% | -2,866,256 (-84.11%) | View |
| 2022-12-16 5:09 pm Sale | 13D | TRICIDA INC TCDAQ | Sibling Capital Ventures LLC | 0 0.000% | -5,563,493 (Position Closed) | View |
| 2022-11-25 4:57 pm Sale | 13D | TRICIDA INC TCDAQ | ORBIMED ADVISORS LLC | 666,667 1.100% | -8,951,245 (-93.07%) | View |
| 2022-10-28 4:05 pm Sale | 13G | TRICIDA INC TCDAQ | Venrock Healthcare Capital Partners II L.P. | 2,982,528 5.400% | -5,899,349 (-66.42%) | View |
| 2022-10-28 4:01 pm Purchase | 13G | TRICIDA INC TCDAQ | CITADEL ADVISORS LLC | 3,407,597 6.100% | 3,407,597 (New Position) | View |
| 2022-10-19 5:07 pm Sale | 13D | TRICIDA INC TCDAQ | Sibling Capital Ventures LLC | 5,563,493 10.000% | -860,000 (-13.39%) | View |
| 2022-09-28 9:20 pm Purchase | 13G | TRICIDA INC TCDAQ | Venrock Healthcare Capital Partners II L.P. | 8,881,877 16.000% | 3,016,717 (+51.43%) | View |
| 2022-06-06 5:31 pm Purchase | 13G | TRICIDA INC TCDAQ | Venrock Healthcare Capital Partners II L.P. | 5,865,160 10.600% | 2,370,309 (+67.82%) | View |
| 2022-05-16 12:57 pm Purchase | 13G | TRICIDA INC TCDAQ | Frazier Life Sciences Public Fund L.P. | 3,582,093 6.300% | 3,582,093 (New Position) | View |
| 2022-03-24 4:15 pm Sale | 13D | TRICIDA INC TCDAQ | Sibling Capital Ventures LLC | 6,423,493 11.700% | -192,841 (-2.91%) | View |
| 2022-02-14 4:39 pm Purchase | 13G | TRICIDA INC TCDAQ | Point72 Asset Management L.P. | 3,284,903 5.900% | 759,365 (+30.07%) | View |
| 2022-02-14 4:19 pm Purchase | 13G | TRICIDA INC TCDAQ | Venrock Healthcare Capital Partners II L.P. | 3,494,851 6.300% | 3,494,851 (New Position) | View |
| 2021-11-23 4:10 pm Sale | 13D | TRICIDA INC TCDAQ | Sibling Capital Ventures LLC | 6,616,334 12.000% | -47,860 (-0.72%) | View |
| 2021-11-17 4:11 pm Purchase | 13G | TRICIDA INC TCDAQ | Deep Track Capital LP | 5,857,829 9.990% | 5,857,829 (New Position) | View |
| 2021-09-10 4:43 pm Sale | 13G | TRICIDA INC TCDAQ | MORGAN STANLEY MS | 619,459 1.200% | -3,915,679 (-86.34%) | View |
| 2021-03-24 5:25 pm Purchase | 13G | TRICIDA INC TCDAQ | Point72 Asset Management L.P. | 2,525,538 5.000% | 2,525,538 (New Position) | View |
| 2021-02-16 12:23 pm Sale | 13G | TRICIDA INC TCDAQ | PRICE T ROWE ASSOCIATES INC | 1,158,637 2.300% | -3,270,581 (-73.84%) | View |